TCL Archive FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer September 27, 2013
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Institute Of Medicine Report Says Insurers Should Pay Patient Care Costs In Clinical Trials February 24, 1989